NCI vs LEVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

NCI

24.1
AI Score
VS
LEVI Wins

LEVI

31.5
AI Score

Investment Advisor Scores

NCI

24score
Recommendation
STRONG SELL

LEVI

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI LEVI Winner
Forward P/E 0 16.7785 Tie
PEG Ratio 1.13 0 Tie
Revenue Growth -50.8% 4.3% LEVI
Earnings Growth 34.0% -22.0% NCI
Tradestie Score 24.1/100 31.5/100 LEVI
Profit Margin 0.2% 8.8% LEVI
Beta 1.00 1.00 Tie
AI Recommendation STRONG SELL EXTENDED LEVI

Relative Price Performance (Last 90 Days)

NCI 1M: +685.3% · 3M: -51.7% LEVI 1M: +23.7% · 3M: +7.4%

Current Technical Phase

NCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 71

RSI (14): 71.3 · Price: $5.81

LEVI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 67.7 · Price: $24.09

Fundamentals Snapshot

Metric NCI LEVI
Market Cap — —
Forward P/E 0.0 14.4
Trailing P/E — 16.0
Revenue (TTM) — —
Revenue Growth -0.5% 0.0%
Gross Margin 0.4% 0.6%
Operating Margin 0.0% 0.1%
EPS -8.26 1.52
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, LEVI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.